Contact your healthcare provider if you have any questions or concerns about your medication
Published research has not evaluated this dual-route approach, but the different distribution profiles suggest the routes are complementary rather than redundant.
doi: 10.1016/0024-3205(84)90454-5
The through-line in all of these is a familiar mechanism of hype: a real but limited laboratory observation is amplified, stripped of its qualifiers, sometimes attributed to the wrong molecule (AHK-Cu results claimed for GHK-Cu), and then presented with a precise-sounding statistic that implies clinical certainty
Primary Handling Editor: Christoph Schmitt, in collaboration with the Nature Metabolism team
Original Study Reference Pyo HK, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, Cho KH, Kim KH